ARCHIVES

MGI Pharma’s Irofulven In Phase III Trial Vs. 5-FU For Advanced Pancreatic Cancer.

This article is from The Cancer Letter archive.

Vol. 27 No. 09 | March 2, 2001

Download PDF Visit The Full Archive

Related Articles

NIh Clinical Center Urged To Create Governing Board

March 15, 1996

Edward Harlow Returns to NCI As Special Assistant to Varmus

January 14, 2011

Abstracts of Papers From ASCO Meeting

April 14, 1978

Clinical Trials Renew By NCI Gets Under Way

May 3, 1985

In Brief: Ozols Promoted At Fox Chase; Greenberger Moves To Pittsburgh; ACR Names New Officers

October 8, 1993

Gastrointestinal SPORE To Be Recompeted

June 23, 1995